Empowered Patient Podcast

Dr. Charles Bridges, the CSO at CorVista Health, has developed a cardiovascular diagnostic platform that uses a simple device to collect various heart signals. The platform then sends that data to the cloud for fast machine learning-based analytics, which can detect conditions like pulmonary hypertension and coronary artery diseases. This test can be given at the point of care and is significant, as these conditions are frequently under-diagnosed due to a lack of accessible testing.  Charles explains, "It's really an amazing breakthrough. Yes, it's a very simple device from the point of view that it's about the size of an iPad. It requires that you connect seven electrodes to the patient. An electrode is identical to what they put on your chest when you get an electrocardiogram, an EKG, and a PPG sensor on the finger. Those of us who made it through COVID-19 probably learned a little about PPG sensors because those we use to measure your arterial oxygen saturation and the most severe cases of COVID-19 were a